Hypnotic approaches for alopecia areata

International Journal of Clinical and Experimental Hypnosis

Volumn 56, Issue 3, 2008, Pages 318-333

  Willemsen, Ria ^a   Vanderlinden, Johan ^b  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; IMIPRAMINE; PAROXETINE;

ALEXITHYMIA; ALOPECIA AREATA; ANXIETY; ARTICLE; CLINICAL TRIAL; DEPRESSION; EGO; FAMILY THERAPY; GUILT; HAIR GROWTH; HUMAN; HYPNOSIS; OUTCOME ASSESSMENT; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; SELF ESTEEM; SOCIAL PHOBIA; TREATMENT OUTCOME; WELLBEING;

ADULT; AFFECTIVE SYMPTOMS; AGED; ALOPECIA AREATA; FEMALE; HUMANS; HYPNOSIS; IMAGINATION; MALE; MEDITATION; PHOBIC DISORDERS; PREGNANCY; SELF CONCEPT; STRESS, PSYCHOLOGICAL; SUGGESTION;

EID: 45949099891     PISSN: 00207144     EISSN: 17445183     Source Type: Journal    
DOI: 10.1080/00207140802041942     Document Type: Article

References (45)

1. Andreoli, E., Mozetta, A., Foglio Bonda, P. G., Provini, A., Cacciaguerra, G., & Paradisi, M. (2001, March). Types of stress in infantile alopecia. Presentation 9th International Congress European Society of Dermatology and Psychiatry, Madrid, Spain.
2. Arca, E., Musabak, U., Akar, A., Erbil, A. H., & Tastan, H. B. (2004). Interferon-gamma in alopecia areata. European Journal of Dermatology, 14, 33-36.
3. Botchkarev, V. A. (2003). Stress and the hair follicle: Exploring the connections. American Journal of Pathology, 162, 709-712.
4. Brajac, I., Tkalcic, M., Dragojevic, D. M., & Gruber, F. (2003). Roles of stress, stress perception and trait-anxiety in the onset and course of alopecia areata. Journal of Dermatology, 30, 871-878.
5. Cipriani, R., & Perini, I. G. (2001). Paroxetine in alopecia areata. International Journal of Dermatology, 40, 600-601.
6. Claudatus, J., Pugliese, S., & d'Ovidio, R. (2001). Alopecia areata. SyM a new approach to therapy and understanding. Presentation European Academy of Dermatology and Venereology. Journal of the European Academy of Dermatology, 15(Suppl 2), 254.
7. Cordan Yazici, A., Basterzi, A., Tot Acar, S., Ustünsoy, D., Ikizoglu, G., Demïrseren, D., et al. (2006). Alopecia areata and alexithymia. Turkish Journal of Psychiatry, 17, 101-106.
8. Derogatis, L. R. (1977). SCL-90: Administration, scoring, and procedures manual for the revised version. Baltimore: Johns Hopkins University School of Medicine Clinical Psychometrics Research Unit.
9. Dewaraja, R., Tanigawa, T., Araki, S., Nataka, A., Kawamura, N., Ago, Y., et al. (1997). Decreased cytotoxic lymphocyte counts in alexithymia. Psychotherapy and Psychosomatics, 66, 83-86.
10. Elzinga, B. M., Bermond, B., & van Dyck, R. (2002). The relationship between dissociative proneness and alexithymia. Psychotherapy and Psychosomatics, 7, 104-111.
11. Guilbaud, O., Corcos, M., Hjalmarsson, L., Loas, G., & Jeammet, P. (2003). Is there a psychoneuroimmunological pathway between alexithymia and immunity? Immune and physiological correlates of alexithymia. Biomedicine and Pharmacotherapy, 57, 292-295.
12. Gulec, A. T., Tanriverdi, N., Duru, C., Saray, Y., & Akcali, C. (2004). The role of psychological factors in alopecia areata and the impact of the disease on the quality of life. Internal Journal of Dermatology, 43, 352-356.
13. Gupta, M. A., & Gupta, A. K. (1996). Psychodermatology: An update. Journal of the American Academy of Dermatology, 34, 1030-1046.
14. Gupta, M. A., Gupta, A. K., & Watteel, G. N. (1997). Stress and alopecia areata : A psychodynamic study. Acta Dermato- Venereologica, 77, 296-298.
15. Harrison, P. V., & Stepanek, P. (1991). Hypnotherapy for alopecia areata. British Journal of Dermatology, 124, 511.
16. Hoffman, R., Eicheler, W., Huth, A., Wenzel, E., & Happle, R. (1996). Cytokines and growth factors influence hair growth in vitro: Possible implications for the pathogenesis and treatment of alopecia areata. Archives of Dermatologic Research, 288, 153-156.
17. Honkalampi, K., Koivumaa-Honkanen, H., Antikainen, R., Haatainen, K., Hintikka, J., et al. (2004). Relationships among alexithymia, adverse childhood experiences, sociodemographic variables, and actual mood disorder: A 2-year clinical follow-up study of patients with major depressive disorder. Psychosomatics, 45, 197-204.
18. Hoppe, K. D., & Bogen, J. E. (1977). Alexithymia in twelve commissurotomized patients. Psychotherapy and Psychosomatics, 28, 148-155.
19. Kabat-Zinn, J., Wheeler, E., Light, T., Skillings, A., Scharf, M. J., Cropley, T. G., et al. (1998). Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemotherapy (PUVA). Psychosomatic Medicine, 60, 625-632.
20. Kano, M., Fukudo, S., Gyoba, J., Kamachi, M., Tagawa, M., Mochizuki, H., et al. (2003). Specific brain processing of facial expressions in people with alexithymia: An H2 15O-PET study. Brain, 126, 1474-1484.
21. Koblenzer, C. S. (1995). Psychotherapy for intractable inflammatory dermatoses. Journal of the American Academy of Dermatology, 32, 609-612.
22. Koo, J. Y. M., Shellow, W. V. R., & Hallman, C. P. (1994). Alopecia areata and increased prevalence of psychiatric disorders. International Journal of Dermatology, 33, 849-850.
23. Lane, R. D., Ahern, G. L., Schwartz, G. E., & Kaszniak, A. W. (1997). Is alexithymia the emotional equivalent of blindsight? Biological Psychiatry, 42, 834-844.
24. Larsen, J. K., Brand, N., Bermond, B., & Hijman, R. (2003). Cognitive and emotional characteristics of alexithymia: A review of neurobiological studies. Journal of Psychosomatic Research, 54, 533-541.
25. MacDonald Hull, S. P., Wood, M. L., Hutchinson, P. E., Sladden, M., & Messenger, A. G. (2003). British Association of Dermatologists. Guidelines for the management of alopecia areata. British Journal of Dermatology, 149, 692-699.
26. Madani, S., & Shapiro, J. (2000). Alopecia areata update. Journal of the American Academy of Dermatology, 42, 549-566.
27. Misery, L., & Rousset, H. (2001). Is alopecia areata a psychosomatic disease? Revue de Medecine Interne, 22, 274-279.
28. Perini, G., Zara, M., Cipriani, R., Carraro, C., Preti, A., Gava, F., et al. (1994). Imipramine in alopecia areata: A double-blind, placebo-controlled study. Psychotherapy and Psychosomatics, 61, 195-198.
29. Peters, E. M., Arck, P. C., & Paus, R. (2006). Hair growth inhibition by psychoemotional stress: A mouse model for neural mechanisms in hair-growth control. Experimental Dermatology, 15, 1-13.
30. Picardi, A., & Abeni, D. (2001). Stressful life events and skin diseases: Disentangling evidence from myth. Psychotherapy and Psychosomatics, 70, 118-136.
31. Picardi, A., Pasquini, P., Cattaruzza, M. S., Gaetano, P., Baliva, G., Melchi, C. F., et al. (2003). Psychosomatic factors in first-onset alopecia areata. Psychosomatics, 44, 374-381.
32. Poot, F., Janne, P., Tordeurs, D., Reynaert, C., & Salomon, V. (2000). Psychosomatics and dermatology: Comparison between objective data and subjective impressions given by patients and dermatologists. Dermatology and Psychosomatics, 1, 19-26.
33. Price, V. H. (2003). Therapy of alopecia areata: On the cusp and in the future. Journal of Investigative Dermatology Symposium Proceedings, 8, 207-211.
34. Ruiz-Doblado, S., Carrizosa, A., & Garcia-Hernandez, M. J. (2003). Alopecia areata: Psychiatric comorbidity and adjustment to illness. International Journal of Dermatology, 42, 434-437.
35. Ruiz-Doblado, S., Carrizosa, A., Garcia-Hernandez, M. J., & Rodriguez-Pichardo, A. (1998). Selective serotonin re-uptake inhibitors (SSRIs) and alopecia areata. International Journal of Dermatology, 38, 796-800.
36. Sayar, K. O., Köse, S., Ebrinç, S., & Çetin, M. (2001). Hopelessness, depression and alexithymia in young Turkish soldiers suffering from alopecia areata. Dermatology and Psychosomatics, 2, 12-15.
37. Shenefelt, P. D. (2000). Hypnosis in dermatology. Archives of Dermatology, 136, 393-399.
38. Taylor, G. J., & Bagby, M. R. (2004). New trends in alexithymia research. Psychotherapy and Psychosomatics, 73, 68-77.
39. Taylor, G. J., Bagby, R. M., & Parker, J. D. A. (1997). Disorders of affect regulation. Alexithymia in medical and psychiatric illness. Cambridge, UK: Cambridge University Press.
40. Teraki, Y., Imanishi, K., & Shiohara T. (1996). Cytokines in alopecia areata: Contrasting cytokine profiles in localized form and extensive form (alopecia universalis). Acta Dermato-Venereologica, 76, 421-423.
41. Teshima, H., Sogawa, H., Mizobe, K., Kuroki, N., & Nakagawa, T. (1991). Application of psychoimmunotherapy in patients with alopecia universalis. Psychotherapy and Psychosomatics, 56, 235-241.
42. Todarello, O., Casamassima, A., Marinaccio, M., & La Pesa, M. W. (1994). Alexithymia, immunity and cervical intraepithelial neoplasia: A pilot study. Psychotherapy and Psychosomatics, 61, 199-204.
43. Vandersteen, P., Boezeman, J., Duller, P., & Happle, R. (1992). Can alopecia areata be triggered by emotional stress? Acta Dermato-Venereologica, 72, 279-280.
44. Willemsen, R., Vanderlinden, J., Deconinck, A., & Roseeuw, D. (2006). Hypnotherapeutic management of alopecia areata. Journal of the American Academy of Dermatology, 55, 233-238.
45. Wood, G. J., Bughi, S., Morrison, J., Tanavoli, S., Tanavoli, S., & Zadeh, H. H. (2003). Hypnosis, differential expression of cytokines by T-cell subsets, and the hypothalamo-pituitary-adrenal axis. American Journal of Clinical Hypnosis, 45, 179-196.